Australia's Echo IQ logs worst day in seven years after FDA setback
09/09/2026 05:08
BUZZ-Australia's Echo IQ logs worst day in seven years after FDA setback ** Shares of Australia's Echo IQ EIQ.AX fall as much as 63.3% to A$0.470, their lowest since February 11
** Stock posts its worst intraday session since early September 2019
** AI medtech firm on Tuesday said the U.S. FDA did not clear application for commercial use of EchoSolv HF, an AI-powered software for detecting heart failure
** Co added that it is assessing multiple administrative and regulatory options available with the FDA
** Around 46.3 mln shares change hands, nearly 15.1x 30-day average
** EIQ up 148.1% YTD
(Reporting by Keshav Singh Chundawat in Bengaluru)
Recent news on EchoIQ
See all newsAustralia's EchoIQ gains most in nearly 3 months after FDA update
Brief: EchoIQ Says FDA Raises No Concerns About Echosolv HF Technology Or Core Functionality
Australia's EchoIQ heads for worst week in seven years after US FDA setback
Australia's Echo IQ logs worst day in seven years after FDA setback
Brief: EchoIQ Requests Trading Halt